Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-117941
Filing Date
2016-05-05
Accepted
2016-05-05 18:39:13
Documents
1
Period of Report
2016-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7080
  Complete submission text file 0001209191-16-117941.txt   8539
Mailing Address C/O ATLAS VENTURE 890 WINTER STREET WALTHAM MA 02451
Business Address
FORMELA JEAN FRANCOIS (Reporting) CIK: 0001030575 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37766 | Film No.: 161625443

Mailing Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139
Business Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances